Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/24
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 05/26/23
End: 08/31/24
Due: 08/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD | NCT06731959 | Aer Therapeutics | user2@example.com | None | 2024-12-31 | 2026-01-31 | 2027-01-31 | - | - | 2025-07-14 |
| Single and Multiple Ascending Dose Study of AER-01 | NCT05862623 | Aer Therapeutics | user2@example.com | None | 2023-05-26 | 2024-08-31 | 2025-08-31 | - | - | 2025-07-14 |